Literature DB >> 28086136

MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.

Wei Liu1, Sheng-Yao Liu2, Yong-Bin He2, Rui-Liang Huang3, Song-Yun Deng2, Guo-Xin Ni4, Bin Yu5.   

Abstract

Previous studies have shown that MiR-451 plays an important role in human osteosarcoma carcinogenesis, but the underlying mechanism by which MiR-451 affects the osteosarcoma has not been fully understood. This study intends to uncover the mechanism by which MiR-451 functions as a tumor suppressor. The expression of MiR-451 in osteosarcoma tissues and osteosarcoma cell lines was monitored by real-time PCR. The proliferation ability was examined by MTT and cell cycle assay. The migration and apoptosis of cells were monitored by migration assay and flow cytometry, respectively. Moreover, the angiogenesis of HUVEC cells transfected with MiR-451 mimics was examined by tube formation assay. The effect of MiR-451 on MIF was determined by luciferase assays and Western blot assay. The results showed that MiR-451 expression level was significantly reduced in the osteosarcoma compared with normal bone tissues. Overexpression of MiR-451 significantly attenuated the proliferation and migration, and induced the apoptosis of osteosarcoma cells. Furthermore, the angiogenesis of HUVEC cells transfected with MiR-451 mimics was assayed and the decreased angiogenic ability was detected compared to the controls. Finally, we demonstrated that MiR-451 overexpression inhibited the malignant behavior of osteosarcoma by downregulating MIF. These findings suggest that MiR-451 may act as a tumor suppressor in osteosarcoma. MiR-451 inhibited cell proliferation, migration and angiogenesis and promoted apoptosis of human osteosarcoma cells, at least partially, by inhibiting the expression of MIF. MiR-451/MIF may be a novel therapeutic target in treatment of osteosarcoma.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Apoptosis; MIF; MiR-451; Migration; Osteosarcoma; Proliferation

Mesh:

Substances:

Year:  2017        PMID: 28086136     DOI: 10.1016/j.biopha.2016.12.121

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  G-Quadruplexes influence pri-microRNA processing.

Authors:  Samuel G Rouleau; Jean-Michel Garant; François Bolduc; Martin Bisaillon; Jean-Pierre Perreault
Journal:  RNA Biol       Date:  2017-12-11       Impact factor: 4.652

Review 3.  Molecular mechanism of microRNAs regulating apoptosis in osteosarcoma.

Authors:  Xueyang Cai; Wei Yin; Chao Tang; Yubao Lu; Yuqi He
Journal:  Mol Biol Rep       Date:  2022-04-26       Impact factor: 2.742

4.  Effect of miR-451 on IVF/ICSI-ET outcome in patient with endometriosis and infertility.

Authors:  Lei Wang; Jing Zhang; Hairu Sun; Xuexia Ji; Shuzhen Zhang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

5.  The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.

Authors:  Akiteru Goto; Masamitsu Tanaka; Makoto Yoshida; Michinobu Umakoshi; Hiroshi Nanjo; Kouya Shiraishi; Motonobu Saito; Takashi Kohno; Sei Kuriyama; Hayato Konno; Kazuhiro Imai; Hajime Saito; Yoshihiro Minamiya; Daichi Maeda
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

6.  Highly expressed placental miRNAs control key biological processes in human cancer cell lines.

Authors:  Daniel Onofre Vidal; Anelisa Ramão; Daniel Guariz Pinheiro; Bruna Rodrigues Muys; Julio Cesar Cetrulo Lorenzi; Cleidson de Pádua Alves; Dalila Luciola Zanette; Greice Andreotti de Molfetta; Geraldo Duarte; Wilson Araújo Silva
Journal:  Oncotarget       Date:  2018-05-04

7.  Downregulation of microRNA‑451 improves cell migration, invasion and tube formation in hypoxia‑treated HUVECs by targeting MIF.

Authors:  Qian Li; Yongqiu Li; Dongsen Zhang; Haifeng Gao; Xuan Gao
Journal:  Mol Med Rep       Date:  2019-06-06       Impact factor: 2.952

8.  Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.

Authors:  Yunxiuxiu Xu; Yu Lai; Linhui Cao; Yanshan Li; Guangcheng Chen; Liang Chen; Hanqin Weng; Tao Chen; Lingyun Wang; Yibiao Ye
Journal:  RNA Biol       Date:  2020-12-31       Impact factor: 4.652

9.  Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients.

Authors:  Eijiro Ueta; Koichiro Tsutsumi; Hironari Kato; Hiroshi Matsushita; Hidenori Shiraha; Masakuni Fujii; Kazuyuki Matsumoto; Shigeru Horiguchi; Hiroyuki Okada
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

Review 10.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Hua Bai; Suhui Wu
Journal:  Onco Targets Ther       Date:  2019-12-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.